The challenge is always in the details, right? The structuring of the data is important to allow for efficient retrieval of it. Really, going through some testing with the consumers of the data to understand what the best way to visualize this is. How can this data make the most sense to the people who are trying to actualize it? And then, also caching on multiple levels.
Get more insights in to Paul's view on data visualization by reading the full transcript and find out more about how the Texas Advanced Computing Center is working with companies to collect and analyze the large amounts of data that is collected through their projects.
This fall, Ted Snyder of Infinity Pharmaceuticals will be on hand at the Clinical Business Expo to present Maximize the Value of Information through Data Warehouse Visualization which will look at how those working in the clinical trial feild can better understand and present their data by capturing it in the power of an image. He also believes that standardization of data collected across trials can help collect better data, agreeing with the views of Novartil on data collection. Find out more of the event by downloading the event agenda. As a reader of this blog, when you register to join us this September and mention code XP1725BLOG, you'll save 15% off the standard rate.
What benefits will data visualization have on clinical trials? Do you think more trials would benefit this method to harvesting information?